Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Relación entre ácido úrico y composición corporal, perfil metabólico, leptina y adiponectina en mujeres posmenopáusicas

Relationship between uric acid and body composition, metabolic profile, leptin and adiponectin in postmenopausal women.

Ginecol Obstet Mex. 2019 mayo;87(5):311-318.

https://doi.org/10.24245/gom.v87i5.2943

Renata Saucedo,1 María Isabel Peña-Cano,2 Jorge Valencia,1 Enrique Morales-Ávila,2 José A. Zavala-Moha,3 Adriana López,4 Marcelino Hernández-Valencia1

1 Unidad de Investigación Médica de Enfermedades Endocrinas, Hospital de Especialidades, CMN Siglo XXI, IMSS, Ciudad de México.
2 Facultad de Química, Universidad Autónoma del Estado de México, Estado de México, México.
3 Departamento de Oncología, Hospital Regional 251, IMSS, Estado de México, México.
4 Departamento de Patología, Hospital Regional 251, IMSS, Estado de México, México.


Corrrespondencia:

Renata Saucedo
sgrenata@yahoo.com

Debe citarse como:

Saucedo R, Peña-Cano MI, Valencia J, Morales-Ávila E, Zavala-Moha JA, López A, Hernández-Valencia M. Relación entre ácido úrico y composición corporal, perfil metabólico, leptina y adiponectina en mujeres posmenopáusicas. Ginecol Obstet Mex. 2019 mayo;87(5):311-318. https://doi.org/10.24245/gom.v87i5.2943

Resumen

OBJETIVO: Evaluar la relación del ácido úrico con los parámetros metabólicos, antropométricos, leptina y adiponectina, en mujeres posmenopáusicas en quienes se incrementa el riesgo de enfermedad cardiovascular.

MATERIALES Y MÉTODOS: Estudio transversal y descriptivo efectuado en mujeres posmenopáusicas. Parámetros de estudio: mediciones antropométricas (bioimpedancia eléctrica), concentraciones de glucosa, colesterol total, LDL-colesterol, HDL-colesterol, triglicéridos (por métodos enzimáticos), adiponectina, leptina e insulina (por radioinmunoensayo). Cálculo de la resistencia a la insulina por el método HOMA-IR. Descripción de variables con promedio y desviación estándar. Análisis estadístico, con prueba de correlación de Pearson, para determinación de la relación entre el ácido úrico y las variables de estudio y regresión múltiple para determinación de los parámetros con mayor influencia en el ácido úrico.

RESULTADOS: Se estudiaron 90 mujeres posmenopáusicas de 55 a 84 años, con edad promedio de 63.7 años. La concentración promedio de ácido úrico de las participantes fue de 4.9 mg/dL. En el análisis bivariado los parámetros antropométricos, el LDL-c, los triglicéridos y la leptina se asociaron positivamente con el ácido úrico y el HDL-c y la adiponectina de forma negativa. En el análisis multivariado la grasa corporal se asoció con el ácido úrico, independientemente del peso corporal (beta = 0.592; p = 0.037).

CONCLUSIONES: En mujeres posmenopáusicas, las concentraciones anormales de ácido úrico se relacionan con un perfil cardiometabólico adverso.

PALABRAS CLAVE: Ácido úrico; posmenopausia; peso corporal; tejido adiposo; colesterol; triglicéridos; resistencia a la insulina.

Abstract

OBJECTIVE: To determine the relation between uric acid and metabolic and anthropometric parameters and adipokines leptin and adiponectin in post-menopausal women.

MATERIALS AND METHODS: A descriptive cross-sectional study was performed in post-menopausal women. Anthropometric measurements were taken by electric bioimpedance, and fasting venous blood samples were taken to determine glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides by enzyme techniques, and levels of adiponectin, leptin and insulin were measured by radioimmunoassay. Insulin resistance was calculated using HOMA-IR. The variables were described with mean and standard deviation. Statistical analysis was performed by Pearson correlation test to evaluate the relation between uric acid and the study variables, and a multiple regression was performed to determine the parameters with greatest influence on uric acid.

RESULTS: The study included 90 post-menopausal women aged 55 to 84 years. The average age of the participants was 63.7 years, and the average concentration of uric acid was 4.9 mg/dL. In bivariate analysis, anthropometric parameters, LDL-cholesterol, triglycerides and leptin showed positive association with uric acid, and HDL-cholesterol and adiponectin had a negative one. In multiple regression analysis, body fat associated with uric acid independent of body weight (beta=0.592, p=0.037).

CONCLUSIONS: Uric acid relates with an adverse cardio-metabolic profile in post-menopausal women.

KEYWORDS: Uric acid; Postmenopause; Body weight; Adipose tissue; Cholesterol; Triglycerides; Insulin resistance.

    1. Wu XW, et al. Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci USA 1989;86(23):9412-16. https://doi.org/10.1073/pnas.86.23.9412
    2. Prado de Oliveira E, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr 2012;4:12. https://doi.org/10.1186/1758-5996-4-12
    3. Johnson RJ, et al. Uric acid, evolution and primitive cultures. Semin Nephrol 2005;25(1):3-8. https://doi.org/10.1016/j.semnephrol.2004.09.002
    4. Martinon F. Mechanisms of uric acid crystal-mediated autoinflammation. Immunol Rev 2010;233(1):218-32. https://doi.org/10.1111/j.0105-2896.2009.00860.x
    5. Coutinho Tde A, et al. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007;20(1):83-9. https://doi.org/10.1016/j.amjhyper.2006.06.015
    6. Levine W, et al. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989;42(3):257-67. https://doi.org/10.1016/0895-4356(89)90061-9
    7. Wingrove CS, et al. The effect of menopause on serum uric acid levels in non-obese healthy women. Metabolism 1998;47(4):435-8. https://doi.org/10.1016/S0026-0495(98)90056-7
    8. Ioannou GN, Boyko EJ. Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality. Atherosclerosis 2013;226(1):220-7. https://doi.org/10.1016/j.atherosclerosis.2012.10.044
    9. Díaz-Martínez AG, et al. Evaluación del tejido adiposo visceral y de la concentración de lípidos en mujeres pre y posmenopáusicas. Ginecol Obstet Mex 2016;84(5):294-300.
    10. Matsuura F, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998;47(8):929-33. https://doi.org/10.1016/S0026-0495(98)90346-8
    11. Facchini F, et al. Relationship between resistance to insulin mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA 1991;266(21):3008-11. doi: 10.1001/jama.1991.03470210076036
    12. Quiñones Galvan A, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995;268(1). https://doi.org/10.1152/ajpendo.1995.268.1.E1
    13. Matthews DR, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-9.
    14. Zárate A, Saucedo R, Basurto L, Martínez C. La enfermedad cardiovascular como amenaza actual para la mujer adulta mayor. La relación con los estrógenos. Ginecol Obstet Mex 2007;75(5):286-92.
    15. Wang Q, et al. Metabolic characterization of menopause: cross-sectional and longitudinal evidence. BMC Med 2018;16(1):17. https://doi.org/10.1186/s12916-018-1008-8
    16. González-Chávez A, Elizondo-Argueta S, Amancio-Chassin O. Relación entre síndrome metabólico e hiperuricemia en población aparentemente sana. Rev Med Hosp Gen Méx 2011;74(3):132-7.
    17. Emmerson BT. The management of gout. N Engl J Med 1996;334(7):445-51. doi: 10.1056/NEJM199602153340707
    18. Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002;29(7):1350-5.
    19. Tsushima Y, et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem 2013;288(38):27138-49. doi: 10.1074/jbc.M113.485094.
    20. Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961-1980. Arthritis Rheum 1983;26(1):87-93.
    21. Nakanishi N, et al. Predictors for development of hyperuricemia: an 8-year longitudinal study in middle-aged Japanese men. Metabolism 2001;50(6):621-6. https://doi.org/10.1053/meta.2001.24196
    22. Nakagawa T, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006;290(3). https://doi.org/10.1152/ajprenal.00140.2005
    23. Cheung, KJ, et al. Xanthine oxidoreductase is a regulator of adipogenesis and PPARg activity. Cell Metab 2007;5(2):115-28. https://doi.org/10.1016/j.cmet.2007.01.005
    24. Masuo K, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003;42(4):474-80. https://doi.org/10.1161/01.HYP.0000091371.53502.D3
    25. Lyngdoh T, et al. Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS One 2012;7(6). https://doi.org/10.1371/journal.pone.0039321
    26. Matsubara K, et al. Relationship between hypertriglyceridemia and uric acid production in primary gout. Metabolism 1989;38(7):698-701. https://doi.org/10.1016/0026-0495(89)90110-8
    27. Kim TH, et al. The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr 2012;4(1):3. https://doi.org/10.1186/1758-5996-4-3
    28. Bedir A, et al. Leptin might be a regulator of serum uric acid concentrations in humans. Jpn Heart J 2003;44(4):527-36. https://doi.org/10.1536/jhj.44.527
    29. Matsubara M, et al. Elevated serum leptin concentrations in women with hyperuricemia. J Atheroscler Thromb 2002;9(1):28-34. https://doi.org/10.5551/jat.9.28
    30. Park JS, et al. Relationships between serum uric acid, adiponectin and arterial stiffness in postmenopausal women. Maturitas 2012;73(4):344-8. https://doi.org/10.1016/j.maturitas.2012.09.009
    31. Defronzo RA, et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237(3):214-23. https://doi.org/10.1152/ajpendo.1979.237.3.E214
    32. Hernández ÁM, et al. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Cuernavaca, México: Instituto Nacional de Salud Pública;2016. https://www.gob.mx/cms/uploads/attachment/file/209093/ENSANUT.pdf
    33. Freedman DS, et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995;141(7):637-44. https://doi.org/10.1093/oxfordjournals.aje.a117479

Comentarios